Can this possibly be accurate? There are photos going around of what is purported to be the inside of the Harbin Sixth...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
PHARMACEUTICAL APPROVALS
Pharmaceuticals approvals are the last step in a long process of government testing. This topic tracks the approval of prescription and over-the-counter pharmaceuticals.
Pharmaceutical Approvals is part of Business Exchange, suggested by
Evan Rappaport.
This topic contains
1,743 news
and
329 blog
items.
Read updated news, blogs, and resources about Pharmaceutical Approvals. Find user-submitted articles and reactions on Pharmaceutical Approvals from
like-minded professionals.
Blogs
Recent blog posts on this topic.
Can this possibly be accurate? There are photos going around of what is purported to be the inside of the Harbin Sixth...
I've written a bit about the struggles to find the biological causes of chronic fatigue syndrome - but perhaps I should...
I've written a bit about the struggles to find the biological causes of chronic fatigue syndrome - but perhaps I should...
So, are half the interesting new results in the medical/biology/med-chem literature impossible to reproduce? I linked...
So, are half the interesting new results in the medical/biology/med-chem literature impossible to reproduce? I linked...
I've had a detailed e-mail from John Choi, Chief Strategy and Business Office for Hua Medicine. That's the company that...
I've had a detailed e-mail from John Choi, Chief Strategy and Business Office for Hua Medicine. That's the company that...
I'm adding a day to the weekend, so science is going to have to march on without me for a while. I do have a few...
When we last spoke about the Avastin-and-breast-cancer story here, the FDA had rescinded its provisional approval for...
Abbott has some difficult times ahead with their fenofibrate franchise. That's TriCor, and its newer formulation,...
Yesterday's look into the Google Ngram data set brought up a discussion in the comments on how good the numbers are in...
We know what clinical trial success rates have been like for the last twenty years or so (hint: not so good).
The "Opinionator" blog at the New York Times is trying here, but there's something not quite right.
This piece is too short to excerpt, so just Read The Whole Thing, as they say. The headline is "Pfizer Breaks...
Now here's a comparison that you don't get to see very often: how much do two large pharma compound collections...
Matthew Herper has a good piece over in Forbes on the speculation that Pfizer might devolve. Here's his breakdown of...
You don't see too many drugs with selenium in them, that's for sure. It's one of those elements that can be used to...
Now here's a piece that I'm looking for good reasons to dismiss. And I think its author, Jim Edwards, wouldn't mind...
I'll freely admit to being very interested in research on aging and lifespan. It's a great subject from a scientific...
Most interesting - here's the FDA's latest statement on Makena, in response to KV Pharmaceuticals sending letters to...
Ah, insider trading. It's the province of Wall Street types in really expensive shirts, right? Like in the movies?...
Here's an interesting funding opportunity from NIH: Recent advances in neuroscience offer unprecedented opportunities...
The Supreme Court came down with a decision the other day (Matrixx Initiatives v. Siracusano) that the headlines say...
I wanted to do some follow-up on the Makena story - the longtime progesterone ester drug that has now been newly...
Top Sources: Pharmaceutical Approvals
- SeekingAlpha.com: Home Page
- DODTracker.com New Deals Feed
- stockerblog.blogspot.com
- What's New at CBER
- RSS from PharmiWeb.com
- futurebiopharma.blogspot.com
- In the Pipeline
- FDA Law Blog
- Health News from Medical News Today
- Medical Device Recalls since November 11, 2009
account